BioDlink Biopharm (Stock Code: 1875.HK) is a global leading contract development and manufacturing organization (CDMO) specializing in biologics, committed to becoming the industry-leading, trusted partner of choice for biopharmaceutical clients. 

Leveraging our advanced one-stop integrated platform, we accelerate client project timelines by providing end-to-end CDMO services—from early R&D to commercial manufacturing for protein-based therapeutics (such as mAb, BsAb), biosimilars, and bioconjugate drugs (such as XDCs/ADCs).

BioDlink operates a large-scale GMP-compliant biomanufacturing facility and adheres to an international quality management system aligned with regulatory requirements in the US, the EU, and China. 

Building on advanced technology platforms and specialized technical/service teams, we empower client projects across diverse regions and countries, spanning Europe, America, Asia, and other emerging markets.

BioDlink operates with a clear service philosophy: “Quality First, Innovation Driven, Success Together” and has assembled an experienced and forward-thinking team. Committed to rigorous quality and compliance, the company nurtures a collaborative ecosystem that empowers its partners and delivers shared success. 

For more information, please visit: https://biodlink.com/

BioDlink

Org chart

Teams

Offices